Fol. Biol. 2020, 66, 148-153

https://doi.org/10.14712/fb2020066040148

Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery

Petr Kačer1,2, J. Pirk1, V. Lánská3, J. A. Hubáček4, V. Adámek5, T. Červinková5, J. Bělohoubek5, O. Auzký5, V. Adámková5

1Cardiocentre; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
2Department of Cardiac Surgery, Královské Vinohrady University Hospital in Prague, Third Faculty of Medicine, Charles University, Prague, Czech Republic
3Medical Statistics Unit; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
4Centre for Experimental Medicine; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
5Department of Preventive Cardiology; Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Received May 2020
Accepted July 2020

Coronary artery bypass graft (CABG) surgery is one of the most commonly performed operations worldwide. We compared genotype frequencies of three major cardiovascular disease (CVD)-associated genetic markers (ANRIL, FTO and 2q36.3 locus) between 753 patients who underwent CABG at the Institute for Clinical and Experimental Medicine (Prague, Czech Republic) and 2,559 controls from the Czech post-MONICA study. Subjects with at least one major A allele in the rs10757274 polymorphism (ANRIL) were more prevalent in patients after CABG than in the controls (81.7 % vs 72.7 %; OR [95 % CI] 1.67 [1.35-2.05]; P < 0.0001). In contrast, variants within the FTO gene (OR 0.87; 95% CI, 0.70-1. 09 in a TT vs. GG comparison, P = 0.24) and 2q36.3 locus (OR 1.16; 95% CI, 0.98-1.37 in a +A vs. CC comparison, P = 0.08) were not significantly associated with CVD in our study. Variants were not associated with anthropometric, biochemical, or clinical characteristics within the patient group. Our study suggests that patients with CABG are more commonly carriers of some but not all CVD-associated alleles.

Funding

This study was supported by the Ministry of Health of the Czech Republic, Grant No. 16-28352A.

References

39 live references